US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist

10.750
+0.320+3.07%

Close Nov 21 16:00 ET

277.74MMarket Cap-51190P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

238.14%2.95M

-82.33%1.26M

-59.75%-2.47M

41.36%6.82M

-86.37%387K

151.26%873K

188.62%7.1M

-226.57%-1.55M

202.12%4.82M

155.50%2.84M

Net income from continuing operations

208.29%627K

-166.70%-3.04M

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Depreciation and amortization

45.55%278K

51.74%261K

18.31%252K

-49.21%901K

28.97%325K

12.35%191K

-85.31%172K

17.68%213K

283.98%1.77M

83.94%252K

Other non cash items

-2.50%39K

-16.90%59K

-13.79%25K

-7.87%117K

-174.19%-23K

33.33%40K

136.67%71K

-19.44%29K

-14.19%127K

-18.42%31K

Change In working capital

161.91%1.29M

106.86%3.14M

-137,900.00%-2.76M

-53.44%3.6M

109.62%1.59M

154.40%491K

-0.13%1.52M

-100.04%-2K

224.34%7.72M

110.55%759K

-Change in receivables

-74.45%-717K

-201.43%-633K

18.88%-829K

-143.08%-1.56M

123.73%84K

38.10%-411K

-452.63%-210K

-121.86%-1.02M

166.73%3.62M

93.04%-354K

-Change in inventory

155.32%130K

165.96%250K

-1,272.50%-1.41M

-4,957.14%-354K

284.21%140K

-570.00%-235K

-1,704.76%-379K

200.00%120K

-101.01%-7K

64.81%-76K

-Change in prepaid assets

-148.77%-159K

8.19%251K

-58.64%79K

-91.54%161K

-159.03%-588K

7.95%326K

-73.21%232K

-80.12%191K

285.38%1.9M

69.45%-227K

-Change in payables and accrued expense

150.55%2.03M

74.48%3.27M

-185.05%-603K

142.10%5.35M

38.06%1.96M

60.59%811K

163.43%1.87M

267.61%709K

586.56%2.21M

223.24%1.42M

Cash from discontinued investing activities

Operating cash flow

238.14%2.95M

-82.33%1.26M

-59.75%-2.47M

41.36%6.82M

-86.37%387K

151.26%873K

188.62%7.1M

-226.57%-1.55M

202.12%4.82M

155.50%2.84M

Investing cash flow

Cash flow from continuing investing activities

-1.88M

72.20%-775K

-6,358.33%-775K

-8.95%-2.79M

99.63%-12K

Net PPE purchase and sale

--0

---14K

--0

-105.50%-38K

-200.00%-12K

Net intangibles purchase and sale

--0

---1.87M

71.82%-775K

---775K

--0

15.38%-2.75M

--0

Cash from discontinued investing activities

Investing cash flow

--0

---1.88M

72.20%-775K

-6,358.33%-775K

--0

-8.95%-2.79M

99.63%-12K

Financing cash flow

Cash flow from continuing financing activities

-4.34%-385K

11.84%-216K

-671.43%-378K

-614.18%-957K

-396.97%-294K

-1,154.29%-369K

-309.40%-245K

87.27%-49K

-134.27%-134K

45.59%99K

Net issuance payments of debt

0.00%-385K

---385K

-200.00%-1.16M

---385K

--0

-156.67%-385K

--0

Proceeds from stock option exercised by employees

--0

20.71%169K

-94.70%7K

-21.12%198K

-190.91%-90K

-54.29%16K

19.66%140K

--132K

-53.60%251K

45.59%99K

Net other financing activities

----

--0

---181K

----

Cash from discontinued financing activities

Financing cash flow

-4.34%-385K

11.84%-216K

-671.43%-378K

-614.18%-957K

-396.97%-294K

-1,154.29%-369K

-309.40%-245K

87.27%-49K

-134.27%-134K

45.59%99K

Net cash flow

Beginning cash position

-17.95%17.69M

13.24%16.66M

31.17%21.39M

13.18%16.31M

64.97%22.07M

26.52%21.57M

-3.42%14.71M

13.18%16.31M

-32.35%14.41M

-41.09%13.38M

Current changes in cash

409.33%2.57M

-84.85%1.04M

-196.37%-4.73M

167.67%5.08M

-123.30%-682K

113.74%504K

277.44%6.86M

-294.05%-1.6M

127.57%1.9M

135.25%2.93M

End cash Position

-8.20%20.26M

-17.95%17.69M

13.24%16.66M

31.17%21.39M

64.97%22.07M

26.52%21.57M

-3.42%14.71M

13.18%16.31M

Free cash flow

238.14%2.95M

-82.33%1.26M

-181.33%-4.36M

197.10%6.04M

-113.72%-388K

123.58%873K

317.82%7.1M

-228.15%-1.55M

125.48%2.03M

133.78%2.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	238.14%2.95M	-82.33%1.26M	-59.75%-2.47M	41.36%6.82M	-86.37%387K	151.26%873K	188.62%7.1M	-226.57%-1.55M	202.12%4.82M	155.50%2.84M
Net income from continuing operations	208.29%627K	-166.70%-3.04M	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Depreciation and amortization	45.55%278K	51.74%261K	18.31%252K	-49.21%901K	28.97%325K	12.35%191K	-85.31%172K	17.68%213K	283.98%1.77M	83.94%252K
Other non cash items	-2.50%39K	-16.90%59K	-13.79%25K	-7.87%117K	-174.19%-23K	33.33%40K	136.67%71K	-19.44%29K	-14.19%127K	-18.42%31K
Change In working capital	161.91%1.29M	106.86%3.14M	-137,900.00%-2.76M	-53.44%3.6M	109.62%1.59M	154.40%491K	-0.13%1.52M	-100.04%-2K	224.34%7.72M	110.55%759K
-Change in receivables	-74.45%-717K	-201.43%-633K	18.88%-829K	-143.08%-1.56M	123.73%84K	38.10%-411K	-452.63%-210K	-121.86%-1.02M	166.73%3.62M	93.04%-354K
-Change in inventory	155.32%130K	165.96%250K	-1,272.50%-1.41M	-4,957.14%-354K	284.21%140K	-570.00%-235K	-1,704.76%-379K	200.00%120K	-101.01%-7K	64.81%-76K
-Change in prepaid assets	-148.77%-159K	8.19%251K	-58.64%79K	-91.54%161K	-159.03%-588K	7.95%326K	-73.21%232K	-80.12%191K	285.38%1.9M	69.45%-227K
-Change in payables and accrued expense	150.55%2.03M	74.48%3.27M	-185.05%-603K	142.10%5.35M	38.06%1.96M	60.59%811K	163.43%1.87M	267.61%709K	586.56%2.21M	223.24%1.42M
Cash from discontinued investing activities
Operating cash flow	238.14%2.95M	-82.33%1.26M	-59.75%-2.47M	41.36%6.82M	-86.37%387K	151.26%873K	188.62%7.1M	-226.57%-1.55M	202.12%4.82M	155.50%2.84M
Investing cash flow
Cash flow from continuing investing activities	0	0	-1.88M	72.20%-775K	-6,358.33%-775K	0	0	0	-8.95%-2.79M	99.63%-12K
Net PPE purchase and sale	--0	--0	---14K	--0	--0	--0	--0	--0	-105.50%-38K	-200.00%-12K
Net intangibles purchase and sale	--0	--0	---1.87M	71.82%-775K	---775K	--0	--0	--0	15.38%-2.75M	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	---1.88M	72.20%-775K	-6,358.33%-775K	--0	--0	--0	-8.95%-2.79M	99.63%-12K
Financing cash flow
Cash flow from continuing financing activities	-4.34%-385K	11.84%-216K	-671.43%-378K	-614.18%-957K	-396.97%-294K	-1,154.29%-369K	-309.40%-245K	87.27%-49K	-134.27%-134K	45.59%99K
Net issuance payments of debt	0.00%-385K	0.00%-385K	---385K	-200.00%-1.16M	---385K	---385K	---385K	--0	-156.67%-385K	--0
Proceeds from stock option exercised by employees	--0	20.71%169K	-94.70%7K	-21.12%198K	-190.91%-90K	-54.29%16K	19.66%140K	--132K	-53.60%251K	45.59%99K
Net other financing activities	----	----	----	----	----	--0	--0	---181K	----	----
Cash from discontinued financing activities
Financing cash flow	-4.34%-385K	11.84%-216K	-671.43%-378K	-614.18%-957K	-396.97%-294K	-1,154.29%-369K	-309.40%-245K	87.27%-49K	-134.27%-134K	45.59%99K
Net cash flow
Beginning cash position	-17.95%17.69M	13.24%16.66M	31.17%21.39M	13.18%16.31M	64.97%22.07M	26.52%21.57M	-3.42%14.71M	13.18%16.31M	-32.35%14.41M	-41.09%13.38M
Current changes in cash	409.33%2.57M	-84.85%1.04M	-196.37%-4.73M	167.67%5.08M	-123.30%-682K	113.74%504K	277.44%6.86M	-294.05%-1.6M	127.57%1.9M	135.25%2.93M
End cash Position	-8.20%20.26M	-17.95%17.69M	13.24%16.66M	31.17%21.39M	31.17%21.39M	64.97%22.07M	26.52%21.57M	-3.42%14.71M	13.18%16.31M	13.18%16.31M
Free cash flow	238.14%2.95M	-82.33%1.26M	-181.33%-4.36M	197.10%6.04M	-113.72%-388K	123.58%873K	317.82%7.1M	-228.15%-1.55M	125.48%2.03M	133.78%2.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data